Stem cell transplant – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 10:29:27 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Stem cell transplant – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on How Rabbit Anti-Human Thymocyte Immunoglobulin Helps Prevent Graft-versus-Host Disease in Children and Adults Undergoing Stem Cell Transplants https://clinicaltrials.eu/trial/study-on-how-rabbit-anti-human-thymocyte-immunoglobulin-helps-prevent-graft-versus-host-disease-in-children-and-adults-undergoing-stem-cell-transplants/ Wed, 29 Apr 2026 14:24:35 +0000 https://clinicaltrials.eu/trial/study-on-how-rabbit-anti-human-thymocyte-immunoglobulin-helps-prevent-graft-versus-host-disease-in-children-and-adults-undergoing-stem-cell-transplants/ This clinical trial is focused on studying the effects of a medication called Thymoglobulin in preventing a condition known as Graft-versus-Host Disease (GvHD). GvHD can occur in patients who receive a type of treatment called allogeneic hematopoietic stem cell transplantation, which is often used for various blood disorders and cancers. The study includes both children and adults who are undergoing this transplantation procedure.

The purpose of the study is to understand how Thymoglobulin, which is an anti-lymphocyte serum, behaves in the body. This medication is given as a solution through an infusion, which means it is delivered directly into the bloodstream. The study will involve monitoring patients who are receiving Thymoglobulin as part of their treatment to see how the medication is processed by the body over time.

Participants in the study will receive Thymoglobulin and may also receive a placebo. The study will track the levels of the medication in the blood and gather data to help understand its effects. This information will help improve the use of Thymoglobulin in preventing GvHD in patients undergoing stem cell transplantation.

]]>